Check out this published article about analysis of HER2 status in breast cancer patients and how automated processes help to decrease variation and errors as well reducing time and labor for laboratory technicians and pathologists showing improvement in cost-effectiveness of the overall method using our products.

Read more about at the following link: 2017 Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients